1 Min Read
Feb 13 (Reuters) - MOBERG PHARMA AB (PUBL):
* Q4 EBITDA SEK 27.0 MILLION (REUTERS POLL: SEK 19.6 MILLION) Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.